Sargent Bickham Lagudis LLC Veracyte, Inc. Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 400 shares of VCYT stock, worth $12,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$12,604
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$259 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$246 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$208 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$132 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$129 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.26B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...